Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Sell
4,548
-3,354
-42% -$182K 0.01% 650
2025
Q4
$387K Buy
7,902
+101
+1% +$4.71K 0.02% 490
2025
Q3
$337K Buy
+7,801
New +$305K 0.02% 532

Other funds holding GSK

Simplicity Wealth's GSK Position: Q1 2026 in Review

Simplicity Wealth reduced its GSK (GSK) stake by 42% in Q1 2026, selling an estimated $182K and leaving 4,548 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #650.

Simplicity Wealth first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. The position peaked at $387K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Simplicity Wealth held 4,548 shares of GSK worth $251K as of Q1 2026.
  • Simplicity Wealth sold 3,354 GSK shares in Q1 2026, an estimated $182K.
  • GSK made up 0.01% of Simplicity Wealth's portfolio in Q1 2026, its #650 holding.
  • Simplicity Wealth first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
  • Simplicity Wealth's GSK position peaked at $387K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.